Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ivu Biologics
Cambridge, Massachusetts, United Statesactivate.org ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Ivu Biologics has developed a biodegradable seed coating that preserves fragile non-spore-forming microbes. This enables their use as biofertilizers to improve crop yields and reduce reliance on synthetic fertilizers. The technology addresses the challenge of keeping these beneficial microbes alive until they reach the soil. Early results indicate improved nutrient uptake by plants and potential for significant environmental impact through reduced chemical fertilizer use.
- Therapeutic areas
- Other
- Modalities
- Microbial seed coatingsdelivery and preservation of non-spore-forming microbes
- Industry
- Non-Drug Biotech
02
Partnerships
MIT Sandbox Innovation Fund Program support
Beyond the preview
Go deeper on Ivu Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ivu Biologics.